Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 40

Sort by

Sort Order Select

Journal Articles

Treosulfan Compared to Busulfan in Allogeneic Haematopoietic Stem Cell Transplantation for Myelofibrosis: A Registry-Based Study from the Chronic Malignancies Working Party of the EBMT

Blood (2023) 142 (Supplement 1): 473.

https://doi.org/10.1182/blood-2023-172704

Published: 2023

Journal Articles

Pre-Transplant Multiparameter Flow Cytometric Measurable Residual Disease in Acute Myeloid Leukemia As an Independent Prognostic Factor for Survival after Myeloablative Allogeneic Hematopoietic Cell Transplantation

Blood (2022) 140 (Supplement 1): 7747–7749.

https://doi.org/10.1182/blood-2022-167407

Published: 2022

Journal Articles

Allogeneic Hematopoietic Cell Transplantation (Allo-HCT) in Patients with Calr -Mutated Myelofibrosis

Blood (2022) 140 (Supplement 1): 10608–10610.

https://doi.org/10.1182/blood-2022-163048

Published: 2022

Journal Articles

Early Hepatotoxicity in Patients with Myelofibrosis after Allogeneic Hematopoietic Cell Transplantation (Allo-HCT)

Blood (2022) 140 (Supplement 1): 7585–7586.

https://doi.org/10.1182/blood-2022-156076

Published: 2022

Journal Articles

Trends in Allogeneic Stem Cell Transplantation for Myelofibrosis in Europe between 1995-2018: An EBMT Retrospective Analysis

Blood (2020) 136 (Supplement 1): 38–39.

https://doi.org/10.1182/blood-2020-134173

Published: 2020

Journal Articles

Outcomes Following Second Allogenic Haematopoietic Cell Transplantation in Patients with Myelofibrosis: A Retrospective Study on Behalf of the Chronic Malignancies Working Party of EBMT

Blood (2019) 134 (Supplement_1): 698.

https://doi.org/10.1182/blood-2019-125802

Published: 2019

Journal Articles

Improved Treatment Outcomes for Patients with Hodgkin Lymphoma Relapsing after Autologous Hematopoietic Stem Cell Transplantation in the Brentuximab Vedotin Era - the Real-Life Report from the Polish Lymphoma Research Group

Blood (2019) 134 (Supplement_1): 5276.

https://doi.org/10.1182/blood-2019-130484

Published: 2019

Journal Articles

Outcome of Allogeneic Haematopoietic Stem Cell Transplantation in Myeloproliferative Neoplasms-Unclassifiable: A Retrospective Study By the Chronic Malignancies Working Party of EBMT

Blood (2019) 134 (Supplement_1): 3335.

https://doi.org/10.1182/blood-2019-121820

Published: 2019

Journal Articles

Impact of Donor-Derived CD34+ Infused Cell Dose on Outcomes of Patients Undergoing Allo-HCT Following Reduced Intensity Regimen for Myelofibrosis:a Study from the Chronic Malignancies Working Party of the EBMT

Blood (2019) 134 (Supplement_1): 3338.

https://doi.org/10.1182/blood-2019-123827

Published: 2019

Journal Articles

Comparison of Myeloablative Conditioning Regimes Based on Either Busulfan or Total Body Irradiation in Combination with Fludarabine for Patients with Acute Myeloid Leukemia. a Study on Behalf of the Polish Adult Leukemia Group

Malgorzata Maria Sobczyk Kruszelnicka, MD, Anna Czyz, MD PhD, Anna Lojko-Dankowska, Magdalena Matuszak, Patrycja Mensah-Glanowska, MD PhD, Barbara Nasilowska-Adamska, Agnieszka Piekarska, Tomasz Czerw, Wlodzimierz Mendrek, Jacek Najda, Maria Sadus-Wojciechowska, Jerzy Holowiecki, Sebastian Giebel

Blood (2018) 132 (Supplement 1): 3391.

https://doi.org/10.1182/blood-2018-99-119073

Published: 2018

Journal Articles

Allogeneic Hematopoietic Cell Transplantation (alloHCT) for Adult Patients with t(4;11)(q21;q23) KMT2A/AFF1 (MLL/AF4) B-Acute Lymphoblastic Leukemia in First Complete Remission (CR1): Favorable Outcome of Patients with Negative Minimal Residual Disease (MRD) Status at Transplant. a Report from the Acute Leukemia Working Party of the European Society for Blood and Bone Marrow Transplantation (ALWP-EBMT)

Blood (2017) 130 (Supplement 1): 669.

https://doi.org/10.1182/blood.V130.Suppl_1.669.669

Published: 2017

Journal Articles

Increased Efficacy of Chemomobilization with Intermediate Dose Cytarabine + G-CSF Compared to G-CSF Alone for Patients with Multiple Myeloma: Results of a Prospective, Randomized Trial

Tomasz Czerw, Wlodzimierz Mendrek, Jacek Najda, Malgorzata Sobczyk-Kruszelnicka, Maria Sadus-Wojciechowska, Katarzyna Soska, Magdalena Glowala-Kosinska, Agata Chwieduk, Wojciech Fidyk, Jerzy Holowiecki, MD PhD, Sebastian Giebel

Blood (2016) 128 (22): 656.

https://doi.org/10.1182/blood.V128.22.656.656

Published: 2016

Journal Articles

Autologous Stem Cell Transplantation for Adult Acute Myelocytic Leukemia in First Remission: Better Outcome Following Busulfan and Melphalan Compared to Busulfan and Cyclophosphamide : A Retrospective Study from the Acute Leukemia Working Party of the EBMT

Norbert Claude Gorin, Pr, MD PhD, Myriam Labopin, MD, Tomasz Czerw, MD, Kurt Leibundgut, MD, Didier Blaise, MD PhD, Pierre Yves Dumas, MD PhD, Damir Nemet, MD PhD, William Arcese, MD, Roberto Foa, MD, Wu Depei, MD, Anne Huynh, MD, Tsila Zuckerman, MD, Ellen Meijer, MDPhD, Seckin Cagirgan, PhD MD, Jan Cornelissen, MD PhD, Mohamad Mohty, MD PhD, Arnon Nagler, MD MSc

Blood (2015) 126 (23): 926.

https://doi.org/10.1182/blood.V126.23.926.926

Published: 2015

Journal Articles

Impact of CD3+ and CD34+ Doses in the Mobilized Peripheral Blood Stem Cell Grafts on the Outcome of Reduced-Intensity Conditioning Allogenic Transplantation from Matched Unrelated Donors for Acute Myeloid Leukemia – an Analysis from the Acute Leukemia Working Party of the EBMT

Tomasz Czerw, Myriam Labopin, MD, Christoph Schmid, Jan J. Cornelissen, Patrice Chevallier, Didier Blaise, MD PhD, Jurgen H Kuball, MDPhD, Noel Milpied, MD PhD, Jean-Yves Cahn, Bruno Lioure, MD PhD, Nathalie Fegueux, MD, Laurence Clement, Anna Sandstedt, Johan Maertens, MD, Gaelle Guillerm, MD, Dominique Bordessoule, MD, Mohamad Mohty, Arnon Nagler

Blood (2014) 124 (21): 190.

https://doi.org/10.1182/blood.V124.21.190.190

Published: 2014

Journal Articles

Association Of Health Care Expenditure With Results Of Allogeneic HSCT For Adults With ALL: An Analysis From Acute Leukemia Working Party Of The EBMT

Sebastian Giebel, MD, Myriam Labopin, MD, Adalberto Ibatici, MD, Paul Browne, MD, Tomasz Czerw, Gérard Socié, MD, PhD, Ali Unal, MD, Slawomira Kyrcz-Krzemien, MD, Andrea Bacigalupo, MD, Hakan Goker, MD, Michael N Potter, MBBS, PhD, Grant McQuaker, MD, Dietrich Beelen, MD, Noel Milpied, MD, PhD, Antonio Campos, MD, Charles Craddock, MD DPhil, Mohamad Mohty, MD, PhD

Blood (2013) 122 (21): 2150.

https://doi.org/10.1182/blood.V122.21.2150.2150

Published: 2013

Journal Articles

Long-Term Follow-up of Autologous Hematopoietic Stem Cell Transplantation (AHSCT) for Acute Myeloid Leukemia (AML): A Survey of 3567 Patients From the Acute Leukemia Working Party of the EBMT.

Tomasz Czerw, MD, Myriam Labopin, Norbert C. Gorin, MD, PhD, Sebastian Giebel, MD, Didier Blaise, MD, Giovanna Meloni, MD, Arnaud Pigneux, MD, PhD, Alberto Bosi, MD, Hendrik Veelken, MD PhD, Felicetto Ferrara, MD, Nicolaas Schaap, MD, PhD, Michele Baccarani, MD, Mohamad Mohty

Blood (2012) 120 (21): 3112.

https://doi.org/10.1182/blood.V120.21.3112.3112

Published: 2012

Journal Articles

Very High Efficacy of Stem Cell Mobilization Using Intermadiate-Dose Cytosine Arabinoside + G-CSF in Patients with Lymphoid Malignancies, Including Predicted and Proven Poor Mobilizers

Tomasz Kruzel, Tomasz Czerw, MD, Maria Sadus-Wojciechowska, MD, Jacek Najda, MD, Magdalena Glowala-Kosinska, PhD, Agata Chwieduk, PhD, Iwona Mitrus, PhD, Andrzej Smagur, PhD, Jerzy Holowiecki, MD, PhD, Sebastian Giebel, MD

Blood (2012) 120 (21): 4131.

https://doi.org/10.1182/blood.V120.21.4131.4131

Published: 2012

Journal Articles

Evaluation of the Toxicity of Total Body Irradation As a Separate Treatment in Preparation for Hematopoietic Cell Transplantation

Sebastian Giebel, MD, Tomasz Kruzel, Maria Sadus-Wojciechowska, MD, Jacek Najda, MD, Tomasz Czerw, MD, Leszek Miszczyk, MD, PhD, Jerzy Holowiecki, MD, PhD

Blood (2011) 118 (21): 4579.

https://doi.org/10.1182/blood.V118.21.4579.4579

Published: 2011

Journal Articles

Effect of Various Concentrations of Dimethyl Sulfoxide (DMSO) on Cell Recovery and Clonogenic Potential of Cryopreserved Peripheral Blood Hematopoietic Progenitors

Andrzej Smagur, Iwona Mitrus, Sebastian Giebel, Maria Sadus-Wojciechowska, Jacek Najda, Tomasz Kruzel, Tomasz Czerw, Joanna Gliwinska, Magdalena Prokop, Magdalena Glowala-Kosinska, Agata Chwieduk, Jerzy Holowiecki, MD, PhD

Blood (2011) 118 (21): 1930.

https://doi.org/10.1182/blood.V118.21.1930.1930

Published: 2011

Journal Articles

Caphosol Mouth Rinse Diminishes Oral Mucositis In Allo-HSCT Recipients.

Miroslaw Markiewicz, MD, PhD, Dzierzak Mietla Monika, MD, Patrycja Zielinska, Tomasz Kruzel, MD, Tomasz Czerw, MD, Slawomira Kyrcz-Krzemien, Prof, MD, PhD

Blood (2010) 116 (21): 3498.

https://doi.org/10.1182/blood.V116.21.3498.3498

Published: 2010

NARROW

Treosulfan Compared to Busulfan in Allogeneic Haematopoietic Stem Cell Transplantation for Myelofibrosis: A Registry-Based Study from the Chronic Malignancies Working Party of the EBMT

Pre-Transplant Multiparameter Flow Cytometric Measurable Residual Disease in Acute Myeloid Leukemia As an Independent Prognostic Factor for Survival after Myeloablative Allogeneic Hematopoietic Cell Transplantation

Allogeneic Hematopoietic Cell Transplantation (Allo-HCT) in Patients with Calr -Mutated Myelofibrosis

Early Hepatotoxicity in Patients with Myelofibrosis after Allogeneic Hematopoietic Cell Transplantation (Allo-HCT)

Trends in Allogeneic Stem Cell Transplantation for Myelofibrosis in Europe between 1995-2018: An EBMT Retrospective Analysis

Outcomes Following Second Allogenic Haematopoietic Cell Transplantation in Patients with Myelofibrosis: A Retrospective Study on Behalf of the Chronic Malignancies Working Party of EBMT

Improved Treatment Outcomes for Patients with Hodgkin Lymphoma Relapsing after Autologous Hematopoietic Stem Cell Transplantation in the Brentuximab Vedotin Era - the Real-Life Report from the Polish Lymphoma Research Group

Outcome of Allogeneic Haematopoietic Stem Cell Transplantation in Myeloproliferative Neoplasms-Unclassifiable: A Retrospective Study By the Chronic Malignancies Working Party of EBMT

Impact of Donor-Derived CD34+ Infused Cell Dose on Outcomes of Patients Undergoing Allo-HCT Following Reduced Intensity Regimen for Myelofibrosis:a Study from the Chronic Malignancies Working Party of the EBMT

Comparison of Myeloablative Conditioning Regimes Based on Either Busulfan or Total Body Irradiation in Combination with Fludarabine for Patients with Acute Myeloid Leukemia. a Study on Behalf of the Polish Adult Leukemia Group

Increased Efficacy of Chemomobilization with Intermediate Dose Cytarabine + G-CSF Compared to G-CSF Alone for Patients with Multiple Myeloma: Results of a Prospective, Randomized Trial

Autologous Stem Cell Transplantation for Adult Acute Myelocytic Leukemia in First Remission: Better Outcome Following Busulfan and Melphalan Compared to Busulfan and Cyclophosphamide : A Retrospective Study from the Acute Leukemia Working Party of the EBMT

Impact of CD3+ and CD34+ Doses in the Mobilized Peripheral Blood Stem Cell Grafts on the Outcome of Reduced-Intensity Conditioning Allogenic Transplantation from Matched Unrelated Donors for Acute Myeloid Leukemia – an Analysis from the Acute Leukemia Working Party of the EBMT

Association Of Health Care Expenditure With Results Of Allogeneic HSCT For Adults With ALL: An Analysis From Acute Leukemia Working Party Of The EBMT

Long-Term Follow-up of Autologous Hematopoietic Stem Cell Transplantation (AHSCT) for Acute Myeloid Leukemia (AML): A Survey of 3567 Patients From the Acute Leukemia Working Party of the EBMT.

Very High Efficacy of Stem Cell Mobilization Using Intermadiate-Dose Cytosine Arabinoside + G-CSF in Patients with Lymphoid Malignancies, Including Predicted and Proven Poor Mobilizers

Evaluation of the Toxicity of Total Body Irradation As a Separate Treatment in Preparation for Hematopoietic Cell Transplantation

Effect of Various Concentrations of Dimethyl Sulfoxide (DMSO) on Cell Recovery and Clonogenic Potential of Cryopreserved Peripheral Blood Hematopoietic Progenitors

Caphosol Mouth Rinse Diminishes Oral Mucositis In Allo-HSCT Recipients.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only